Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 8 Oct 20 EFFECT Notice of effectiveness
- 7 Oct 20 424B3 Prospectus supplement
- 2 Oct 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 17 Sep 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
7 Aug 20 S-4 Registration of securities issued in business combination transactions
CERE similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 10, 2020 with respect to the consolidated financial statements of Cerevel Therapeutics, Inc. included in the Proxy Statement of ARYA Sciences Acquisition Corp II that is made a part of the Registration Statement (Form S-4) and Prospectus of ARYA Sciences Acquisition Corp II for the registration of 102,336,166 shares of its common stock and 5,149,666 warrants to purchase shares of its common stock.
/s/ Ernst & Young LLP
Boston, Massachusetts
August 7, 2020